872 related articles for article (PubMed ID: 8623495)
1. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
2. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
3. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
[No Abstract] [Full Text] [Related]
4. Reversal of accelerated renal allograft rejection with FK 506.
Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
[TBL] [Abstract][Full Text] [Related]
5. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
6. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
[No Abstract] [Full Text] [Related]
7. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
8. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
[No Abstract] [Full Text] [Related]
9. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Washburn WK; Shaffer D; Simpson MA; Conway P; Madras PN; Monaco AP
Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
[No Abstract] [Full Text] [Related]
10. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
Woodle ES; Thistlethwaite JR; Gordon JH
Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
[No Abstract] [Full Text] [Related]
11. Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3).
Noël C; Hazzan M; Coppin MC; Pruvot FR; Bridoux F; Lelièvre G
Transplant Proc; 1995 Aug; 27(4):2438-9. PubMed ID: 7652870
[No Abstract] [Full Text] [Related]
12. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
[No Abstract] [Full Text] [Related]
15. Tacrolimus rescue therapy for renal transplant rejection.
Jordan ML; Shapiro R; Naraghi R; Smith D; Vivas C; Gritsch HA; Scantlebury V; Randhawa P; Demetris AJ; Fung JJ; Starzl TE
Transplant Proc; 1996 Aug; 28(4):2119-20. PubMed ID: 8769174
[No Abstract] [Full Text] [Related]
16. FK 506 induction and rescue therapy in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
[No Abstract] [Full Text] [Related]
17. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
18. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
[No Abstract] [Full Text] [Related]
19. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
[No Abstract] [Full Text] [Related]
20. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Scott-Douglas N; Zimmerman D; Klassen J
Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
